Home › Companies › VERONA PHARMA PLC › 2023-2024
Compiled from SEC Form N-PX filings and VERONA PHARMA PLC’s Form 8-K, filed April 30, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of April 26, 2024: 14 items on VERONA PHARMA PLC’s Form 8-K, filed April 30, 2024: 14 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VERONA PHARMA PLC in the interactive database Compare manager voting policies
These tallies are VERONA PHARMA PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 30, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. To re-elect Lisa Deschamps as a Director of the Company | 615,922,153 | 2,039,440 | -- | 780,158 | -- | 99.6% | Not verified | — |
| 2. To re-elect Martin Edwards as a Director of the Company | 617,654,873 | 309,040 | -- | 777,838 | -- | 99.9% | Not verified | — |
| 3. To re-elect Sven Anders Ullman as a Director of the Company | 590,081,657 | 27,882,176 | -- | 777,918 | -- | 95% | Not verified | — |
| 4. To re-elect Christina Ackerman as a Director of the Company | 617,786,657 | 169,976 | -- | 785,118 | -- | 99.9% | Not verified | — |
| 5. To re-elect Michael Austwick as a Director of the Company | 617,807,153 | 170,296 | -- | 764,302 | -- | 99.9% | Not verified | — |
| 6. To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended December 31, 2023 and the report of the auditors thereon (the "2023 U.K. Annual Report") | 616,905,143 | 1,179,344 | -- | 657,264 | -- | 99.8% | Not verified | — |
| 7. To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended December 31, 2023, as set out on pages 36 to 57 of the 2023 U.K. Annual Report | 593,000,121 | 24,709,190 | -- | 1,032,440 | -- | 96% | Not verified | — |
| 8. To receive and approve the U.K. Directors' Remuneration Policy, as set out on pages 47 to 57 of the 2023 U.K. Annual Report, which, if approved, will take effect upon conclusion of the AGM | 592,664,317 | 24,906,426 | -- | 1,171,008 | -- | 96% | Not verified | — |
| 9. To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration (by way of fee) in accordance with Article 21.4 of the Company's Articles of Association to £750,000 per annum on an ongoing basis | 589,238,589 | 28,269,274 | -- | 1,233,888 | -- | 95% | Not verified | — |
| 10. To appoint Ernst & Young LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders | 603,137,815 | 195,320 | -- | 15,408,616 | -- | 99.9% | Not verified | — |
| 11. To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2024 | 618,024,719 | 65,608 | -- | 651,424 | -- | 99.9% | Not verified | — |
| 12. To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers | 594,069,521 | 23,464,550 | -- | 1,207,680 | -- | 96% | Not verified | — |
| 13. To authorize the Directors generally and unconditionally for the purposes of Section 551 of the U.K. Companies Act 2006 (the "Companies Act") to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to co | 588,880,425 | 28,995,238 | -- | 866,088 | -- | 95% | Not verified | — |
| 14. Subject to and conditional upon the passing of resolution 13 above, to authorize the Directors pursuant to Section 570 and 573 of the Companies Act to allot equity securities (as defined in Section 560 of the Companies Act) for cash pursuant to the authori | 616,327,627 | 1,576,996 | -- | 837,128 | -- | 99.7% | Not verified | — |
Source: VERONA PHARMA PLC, Form 8-K, filed with the SEC on April 30, 2024 — read the filing on EDGAR.
Each item below shows how the 126 asset managers that disclosed a VERONA PHARMA PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERONA PHARMA PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-elect Christina Ackermann as a director of the Company.
VERONA PHARMA PLC’s own tally for this item (“4. To re-elect Christina Ackerman as a Director of the Company”): 617,786,657 for, 169,976 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,297,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: To re-elect Lisa Deschamps as a director of the Company.
VERONA PHARMA PLC’s own tally for this item (“1. To re-elect Lisa Deschamps as a Director of the Company”): 615,922,153 for, 2,039,440 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,293,963 for, 3,367 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 21,265 | 3,299 | 0 | 0 | Mixed |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-elect Martin Edwards as a director of the Company.
VERONA PHARMA PLC’s own tally for this item (“2. To re-elect Martin Edwards as a Director of the Company”): 617,654,873 for, 309,040 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,297,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-elect Michael Austwick as a director of the Company.
VERONA PHARMA PLC’s own tally for this item (“5. To re-elect Michael Austwick as a Director of the Company”): 617,807,153 for, 170,296 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,297,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To re-elect Sven Anders Ullman as a director of the Company.
VERONA PHARMA PLC’s own tally for this item (“3. To re-elect Sven Anders Ullman as a Director of the Company”): 590,081,657 for, 27,882,176 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,297,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To approve an increase in the maximum aggregate level of NonExecutive Director annual remuneration (by way of fee) in accordance with Article 21.4 of the Companys Articles of Association to 750,000 per annum on an ongoing basis.
VERONA PHARMA PLC’s own tally for this item (“9. To approve an increase in the maximum aggregate level of Non-Executive Director annual remuneration (by way of fee) in accordance with Article 21.4 of the Company's Articles of Association to £750,000 per annum on an ”): 589,238,589 for, 28,269,274 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 9,353,020 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0 | 2,527,382 | 0 | 0 | Against |
| CIDEL ASSET MANAGEMENT INC | 576 | 0 | 0 | 0 | For |
| Keel Point, LLC | 310 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 886 for, 2,527,382 against.
Combines 3 wordings of this item as funds reported it.
99.2% of fund votes cast · no official result
Description as filed by funds: To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section 561(1) of the Companies Act does not apply to any such allotment.
The 34 asset managers below reported 9,283,545 for, 69,785 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,659,263 | 65,320 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 0 | 4,458 | 0 | 0 | Against |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of 8,345,745 (being up to a maximum of 166,914,908 shares representing 25% of the Companys existing ordinary share capital as at the close of business on March 13, 2024 (being the latest practicable date prior to publication of this document)).
VERONA PHARMA PLC’s own tally for this item (“13. To authorize the Directors generally and unconditionally for the purposes of Section 551 of the U.K. Companies Act 2006 (the "Companies Act") to exercise all the powers of the Company to allot shares in the Company o”): 588,880,425 for, 28,995,238 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 6,130,936 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| Victory Capital | 1,971 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,100 | 0 | 0 | 0 | For |
| Principal | 1,039 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 671 | 0 | 0 | 0 | For |
| Keel Point, LLC | 310 | 0 | 0 | 0 | For |
| MassMutual | 185 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 176 | 0 | 0 | 0 | For |
95% Majority: yes · of votes cast
Description as filed by funds: To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds8,345,745 (being up to a maximum of 166,914,908 shares representing 25% of the Company's existing ordinary share capital as at the close of business on March 13, 2024 (being the latest practicable date prior to publication of this document)).
VERONA PHARMA PLC’s own tally for this item (“13. To authorize the Directors generally and unconditionally for the purposes of Section 551 of the U.K. Companies Act 2006 (the "Companies Act") to exercise all the powers of the Company to allot shares in the Company o”): 588,880,425 for, 28,995,238 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,157,067 for, 65,327 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,659,263 | 65,320 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
| Invesco | 68 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 7 | 0 | 0 | Against |
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended 31 December 2023.
VERONA PHARMA PLC’s own tally for this item (“6. To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended December 31, 2023 and the report of the auditors thereon (the "2023 U.K. Annual Report")”): 616,905,143 for, 1,179,344 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,297,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,187,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
VERONA PHARMA PLC’s own tally for this item (“12. To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers”): 594,069,521 for, 23,464,550 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 541,647 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 0 | 106,781 | 0 | 0 | Against |
| Neuberger Berman | 0 | 96,259 | 0 | 0 | Against |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 3,299 | 21,265 | 0 | 0 | Mixed |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 8,014 | 1,232 | 0 | 0 | Mixed |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 8,585,836 for, 767,184 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6,214,670 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 3,610,108 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 3,444,363 | 0 | 0 | 0 | For |
| Wellington | 3,303,090 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 3,187,415 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 2,936,957 | 0 | 0 | 0 | For |
| Carlyle Group Inc. | 2,457,500 | 0 | 0 | 0 | For |
| Fidelity | 2,255,256 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 1,375,557 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 0 | 1,229,810 | 0 | 0 | Against |
| Janus Henderson | 1,139,534 | 0 | 0 | 0 | For |
| Caligan Partners LP | 1,049,216 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 1,027,468 | 0 | 0 | 0 | For |
| Ally Bridge Group (NY) LLC | 783,083 | 0 | 0 | 0 | For |
| Woodline Partners LP | 752,980 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 703,885 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 0 | 506,798 | 0 | 0 | Against |
| American Century | 504,258 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 412,995 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 347,500 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 326,621 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 8,642 | 266,798 | 0 | 0 | Against |
| Aisling Capital Management LP | 259,260 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 254,994 | 0 | 0 | 0 | For |
Institutional-manager reports, all 101 managers: 39,050,422 for, 2,680,553 against, 177 withheld, 2,904 not voted. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended 31 December 2023
VERONA PHARMA PLC’s own tally for this item (“7. To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended December 31, 2023, as set out on pages 36 to 57 of the 2023 U.K. Annual Report”): 593,000,121 for, 24,709,190 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 541,647 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 0 | 106,781 | 0 | 0 | Against |
| Neuberger Berman | 0 | 96,259 | 0 | 0 | Against |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 3,299 | 21,265 | 0 | 0 | Mixed |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 8,014 | 1,232 | 0 | 0 | Mixed |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 8,585,836 for, 767,184 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 3,187,415 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 1,375,557 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 916,981 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 0 | 506,798 | 0 | 0 | Against |
| Affinity Asset Advisors, LLC | 412,995 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 326,621 | 0 | 0 | 0 | For |
| Aisling Capital Management LP | 259,260 | 0 | 0 | 0 | For |
| MOODY ALDRICH PARTNERS LLC | 234,462 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 212,000 | 0 | 0 | Against |
| Polar Asset Management Partners Inc. | 96,500 | 0 | 0 | 0 | For |
| Treasurer of the State of North Carolina | 0 | 59,107 | 0 | 0 | Against |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 24,007 | 0 | 0 | Against |
| US BANK NATIONAL ASSOCIATION | 23,179 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 18,556 | 0 | 0 | 0 | For |
| Orion Portfolio Solutions, LLC | 18,556 | 0 | 0 | 0 | For |
| S&CO INC | 12,026 | 0 | 0 | 0 | For |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 0 | 8,000 | 0 | 0 | Against |
| D.A. DAVIDSON & CO. | 0 | 7,600 | 0 | 0 | Against |
| LPL Financial LLC | 0 | 6,967 | 0 | 0 | Against |
| TRUIST FINANCIAL CORP | 0 | 5,000 | 0 | 0 | Against |
| Matisse Capital | 4,400 | 0 | 0 | 0 | For |
| Heck Capital Advisors, LLC | 4,160 | 0 | 0 | 0 | For |
| JPMorgan | 2,974 | 0 | 0 | 0 | For |
| Chicago Partners Investment Group LLC | 2,809 | 0 | 0 | 0 | For |
| Centiva Capital, LP | 0 | 2,271 | 0 | 0 | Against |
Institutional-manager reports, all 36 managers: 6,898,158 for, 833,616 against, 177 withheld. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To receive and approve the U.K. Directors' Remuneration Policy.
VERONA PHARMA PLC’s own tally for this item (“8. To receive and approve the U.K. Directors' Remuneration Policy, as set out on pages 47 to 57 of the 2023 U.K. Annual Report, which, if approved, will take effect upon conclusion of the AGM”): 592,664,317 for, 24,906,426 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 8,586,146 for, 767,184 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 541,647 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 0 | 106,781 | 0 | 0 | Against |
| Neuberger Berman | 0 | 96,259 | 0 | 0 | Against |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 3,299 | 21,265 | 0 | 0 | Mixed |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 8,014 | 1,232 | 0 | 0 | Mixed |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To appoint Ernst & Young LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders.
VERONA PHARMA PLC’s own tally for this item (“10. To appoint Ernst & Young LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders”): 603,137,815 for, 195,320 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,353,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2024.
VERONA PHARMA PLC’s own tally for this item (“11. To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2024”): 618,024,719 for, 65,608 against, per its Form 8-K filed April 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 9,353,330 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 2,243,520 | 0 | 0 | 0 | For |
| Fidelity | 1,724,583 | 0 | 0 | 0 | For |
| Vanguard | 1,304,406 | 0 | 0 | 0 | For |
| Federated Hermes | 1,043,864 | 0 | 0 | 0 | For |
| Prudential/PGIM | 541,647 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 492,127 | 0 | 0 | 0 | For |
| American Century | 487,463 | 0 | 0 | 0 | For |
| Hartford | 485,679 | 0 | 0 | 0 | For |
| BlackRock | 220,436 | 0 | 0 | 0 | For |
| Legg Mason | 172,200 | 0 | 0 | 0 | For |
| John Hancock | 113,011 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 106,781 | 0 | 0 | 0 | For |
| Neuberger Berman | 96,259 | 0 | 0 | 0 | For |
| Nationwide | 76,547 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,006 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 45,700 | 0 | 0 | 0 | For |
| New York Life | 34,260 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 24,564 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 18,734 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,420 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 16,749 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 9,246 | 0 | 0 | 0 | For |
| BNY Mellon | 5,300 | 0 | 0 | 0 | For |
| ProShares | 4,843 | 0 | 0 | 0 | For |
| State Street | 4,458 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 647,372,062 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MUTUAL FUND SERIES TRUST | 0.35% |
| 2 | Fidelity | 0.27% |
| 3 | Vanguard | 0.20% |
| 4 | Federated Hermes | 0.16% |
| 5 | Prudential/PGIM | 0.08% |
| 6 | JANUS INVESTMENT FUND | 0.08% |
| 7 | American Century | 0.08% |
| 8 | Hartford | 0.08% |
| 9 | BlackRock | 0.03% |
| 10 | Legg Mason | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 0.96% |
| 2 | Vivo Capital, LLC | 0.56% |
| 3 | ORBIMED ADVISORS LLC | 0.53% |
| 4 | Wellington | 0.51% |
| 5 | Deep Track Capital, LP | 0.49% |
| 6 | PERCEPTIVE ADVISORS LLC | 0.45% |
| 7 | Carlyle Group Inc. | 0.38% |
| 8 | Fidelity | 0.35% |
| 9 | MAVERICK CAPITAL LTD | 0.21% |
| 10 | JENNISON ASSOCIATES LLC | 0.19% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| RA Capital Management affiliates | 9.27% | DEF14A |
| New Enterprise Associates affiliates | 7.17% | DEF14A |
| Growth Equity Opportunities Fund IV, LLC | 6.90% | 13D |
| FMR LLC | 6.06% | DEF14A |
| David Zaccardelli, Pharm.D. | 1.96% | DEF14A |
| Mark W. Hahn | 1.82% | DEF14A |
| BlackRock | 0.59% | 13F |
| Kathleen Rickard, M.D. | 0.35% | DEF14A |
| Goldman Sachs | 0.30% | 13F |
| Morgan Stanley | 0.24% | 13F |
Percentages above are of 647,372,062 shares outstanding, as reported by VERONA PHARMA PLC on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERONA PHARMA PLC’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At VERONA PHARMA PLC's shareholder meeting held April 26, 2024, in the 2023-2024 proxy season, 126 asset managers reported how they voted in their SEC Form N-PX filings, covering 974 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VERONA PHARMA PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 30, 2024.
VERONA PHARMA PLC proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.